HIGHLIGHTS
- who: Unknown from the Germany Germany have published the research: Evaluation of Self-care Activities and Quality of Life in Patients With Type 2 Diabetes Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: the DePRO Proof-of-Concept Observational Study, in the Journal: (JOURNAL)
- what: The aim of the DePRO study was to assess the feasibility of a fully digital data-capture workflow the authentication of participants via drug packaging 2D matrix codes in patients with type 2 diabetes mellitus (T2DM) who use metformin. The aim was to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.